Scholarlink

<p>PRRSV poses a persistent threat to the global swine industry, yet effective control measures remain limited. This study evaluated the anti-PRRSV effects of α-mannan through in <i>vitro</i> and in <i>vivo</i> experiments. In <i>vitro</i>, α-mannan (25–100&#xa0;µg/mL) showed no cytotoxicity and did not directly inhibit PRRSV replication. However, it exhibited immunomodulatory activity by inducing IFN-γ expression and suppressing PRRSV-induced elevation of TNF-α and IL-6. In <i>vivo</i>, piglets receiving prophylactic oral α-mannan (50&#xa0;mg/day for 15 days before and after challenge) showed trends toward reduced PRRSV RNA loads in serum and lung tissue and alleviated pulmonary pathology (based on descriptive observations), shortened duration of detectable PRRSV RNA in oral swabs, delayed fever onset, and all survived to the end of the observation period (15 dpi). In conclusion, prophylactic α-mannan was associated with reduced PRRSV RNA load and attenuated disease severity. These findings suggest α-mannan as a promising candidate for PRRSV control.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Prophylactic immunomodulation with α-mannan attenuates PRRSV-induced disease in piglets

  • 期刊论文

  • 发表日期：

    2026年7月9日

查看全文
  • Mingxiang Li,
  • Min Wang,
  • Hongmei Yin,
  • Jun Zhou,
  • Guiying Hao,
  • Guangwen Yan

摘要

PRRSV poses a persistent threat to the global swine industry, yet effective control measures remain limited. This study evaluated the anti-PRRSV effects of α-mannan through in vitro and in vivo experiments. In vitro, α-mannan (25–100 µg/mL) showed no cytotoxicity and did not directly inhibit PRRSV replication. However, it exhibited immunomodulatory activity by inducing IFN-γ expression and suppressing PRRSV-induced elevation of TNF-α and IL-6. In vivo, piglets receiving prophylactic oral α-mannan (50 mg/day for 15 days before and after challenge) showed trends toward reduced PRRSV RNA loads in serum and lung tissue and alleviated pulmonary pathology (based on descriptive observations), shortened duration of detectable PRRSV RNA in oral swabs, delayed fever onset, and all survived to the end of the observation period (15 dpi). In conclusion, prophylactic α-mannan was associated with reduced PRRSV RNA load and attenuated disease severity. These findings suggest α-mannan as a promising candidate for PRRSV control.